文摘
| Figures/TablesFigures/Tables | ReferencesReferencescoding="UTF-8"?>
class="h3">Summary
Alzheimer鈥檚 disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2伪 (eIF2伪-P), and AD brains exhibit聽elevated phospho-PKR and eIF2伪-P levels. Whether and how PKR and eIF2伪-P participate in聽defective brain insulin signaling and cognitive impairment in AD are unknown. We report that 尾-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor 伪 (TNF-伪)-dependent manner, resulting in eIF2伪-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2伪-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to聽trigger eIF2伪-P and cognitive impairment in PKR鈭?鈭?/sup> and TNFR1鈭?鈭?/sup> mice. Bolstering insulin signaling rescued phospho-PKR and eIF2伪-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.